Contact this trialFirst, we need to learn more about you.
Cytokine
Sargramostim for Alzheimer's Disease
Recruiting0 awardsPhase 2
Aurora, Colorado
This trial will test sargramostim, a medicine that helps the body produce more blood cells, in people with mild-to-moderate Alzheimer's disease. The goal is to see if it is safe and can slow down or improve symptoms of Alzheimer's. The medicine might help by boosting cells that protect or repair brain cells.
Fill-in a few details and create your profileSave answers to your profile & unlock recommendations.
We will keep your details privateWe won't share unless you give us permission. By completing this form you agree to our privacy policy and terms of service.
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.
By clicking start, you agree to our
terms of service